Mapping antigenic diversity and strain specificity of mumps virus: A bioinformatics approach

Virology

Volumn 359, Issue 2, 2007, Pages 436-446

  Kulkarni Kale, Urmila ^a   Ojha, Janaki ^a   Manjari, G Sunitha ^a   Deobagkar, Deepti D ^a   Mallya, Asha D ^b   Dhere, Rajeev M ^b   Kapre, Subhash V ^b  

^a UNIVERSITY OF PUNE   (India)

^b India Ltd   (India)

Author keywords

Bioinformatics; Conformational epitope; Hemagglutinin neuraminidase; HN; Homology model; Molecular immunology; Mumps virus; Sequential epitope; Wild and vaccine strain

Indexed keywords

EPITOPE; HN PROTEIN; MEMBRANE ANTIGEN; MUMPS VACCINE; NEUTRALIZING ANTIBODY;

ANTIGENICITY; ARTICLE; CONFORMATION; DRUG EFFICACY; GENETIC VARIABILITY; MUMPS; MUMPS VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PARAMYXOVIRUS; PRIORITY JOURNAL; PROTEIN STRUCTURE; STRAIN DIFFERENCE; VACCINATION; VIRUS NEUTRALIZATION; VIRUS STRAIN;

ANTIGENIC VARIATION; ANTIGENS, VIRAL; COMPUTATIONAL BIOLOGY; GENETIC SPECIATION; MODELS, MOLECULAR; MUMPS VIRUS; PROTEIN CONFORMATION; SPECIES SPECIFICITY; VIRAL PROTEINS;

MUMPS VIRUS; PARAMYXOVIRIDAE;

EID: 33847009910     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.09.040     Document Type: Article

References (78)

1. Afzal M.A., Pickford A.R., Forsey T., Heath A.B., and Minor P.D. The Jeryl Lynn vaccine strain of mumps virus is a mixture of two distinct isolates. J. Gen. Virol. 74 (1993) 917-920
2. Afzal M.A., Buchanan J., Dias J.A., Cordeiro M., Bentley M.L., Shorrock C.A., and Minor P.D. RT-PCR based diagnosis and molecular characterisation of mumps viruses derived from clinical specimens collected during the 1996 mumps outbreak in Portugal. J. Med. Virol. 52 (1997) 349-353
3. Afzal M.A., Buchanan J., Heath A.B., and Minor P.D. Clustering of mumps virus isolates by SH gene sequence only partially reflects geographical origin. Arch. Virol. 142 (1997) 227-238
4. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., and Lipman D.J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25 (1997) 3389-3402
5. Amexis G., Fineschi N., and Chumakov K. Correlation of genetic variability with safety of mumps vaccine Urabe AM9 strain. Virology 287 (2001) 234-241
6. Amexis G., Rubin S., Chizhikov V., Pelloquin F., Carbone K., and Chumakov K. Sequence diversity of Jeryl Lynn strain of mumps virus: quantitative mutant analysis for vaccine quality control. Virology 300 (2002) 171-179
7. Apweiler R., Hermjakob H., and Sharon N. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim. Biophys. Acta 1473 (1999) 4-8
8. Benson D.A., Karsch-Mizrachi I., Lipman D.J., Ostell J., and Wheeler D.L. GenBank. Nucleic Acids Res. 34 (2006) D16-D20 (Database issue)
9. Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., Shindyalov I.N., and Bourne P.E. The protein data bank. Nucleic Acids Res. 28 (2000) 235-242
10. Brown E.G., Dimock K., and Wright K.E. The Urabe AM9 mumps vaccine is a mixture of viruses differing at amino acid 335 of the hemagglutinin-neuraminidase gene with one form associated with disease. J. Infect Dis. 174 (1996) 619-622
11. CDC, 2006. Update: multistate outbreak of mumps - United States, January 1 - May 2, 2006. MMWR 55, 559-563.
12. Chenna R., Sugawara H., Koike T., Lopez R., Gibson T.J., Higgins D.G., and Thompson J.D. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res. 31 (2003) 3497-3500
13. Cole K.S., Steckbeck J.D., Rowles J.L., Desrosiers R.C., and Montelaro R.C. Removal of N-linked glycosylation sites in the V1 region of simian immunodeficiency virus gp120 results in redirection of B-cell responses to V3. J. Virol. 78 (2004) 1525-1539
14. Crennell S., Takimoto T., Portner A., and Taylor G. Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat. Struct. Biol. 7 (2000) 1068-1074
15. Cusi M.G., Fischer S., Sedlmeier R., Valassina M., Valensin P.E., Donati M., and Neubert W.J. Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein. Virus Res. 74 (2001) 133-137
16. Davies D.R., and Cohen G.H. Interactions of protein antigens with antibodies. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 7-12
17. DeWeese-Scott C., and Moult J. Molecular modeling of protein function regions. Proteins 55 (2004) 942-961
18. Flower D.R., McSparron H., Blythe M.J., Zygouri C., Taylor D., Guan P., Wan S., Coveney P.V., Walshe V., Borrow P., and Doytchinova I.A. Computational vaccinology: quantitative approaches. Novartis Found. Symp. 254 (2003) 102-120
19. Flynn M., and Mahon B.P. Cell mediated and humoral immune responses to mumps virus: recent developments. In: Pandalai S.G. (Ed). Recent Research Developments in Virology (2003), Research Signpost, Trivandrum, India 97-115
20. Folb P.I., Bernatowska E., Chen R., Clemens J., Dodoo A.N., Ellenberg S.S., Farrington C.P., John T.J., Lambert P.H., Macdonald N.E., Miller E., Salisbury D., Schmitt H.J., Siegrist C.A., and Wimalaratne O. A global perspective on vaccine safety and public health: the Global Advisory Committee on Vaccine Safety. Am. J. Public Health 94 (2004) 1926-1931
21. Furesz J. Safety of live mumps virus vaccines. J. Med. Virol. 67 (2002) 299-300
22. Galazka A.M., Robertson S.E., and Kraigher A. Mumps and mumps vaccine: a global review. Bull. World Health Organ 77 (1999) 3-14
23. Hobohm U., and Sander C. Enlarged representation set of protein structures. Protein Sci. 3 (1994) 522-524
24. Ivancic J., Gulija T.K., Forcic D., Baricevic M., Jug R., Mesko-Prejac M., and Mazuran R. Genetic characterization of L-Zagreb mumps vaccine strain. Virus Res. 109 (2005) 95-105
25. Jin L., Rima B., Brown D., Orvell C., Tecle T., Afzal M., Uchida K., Nakayama T., Song J.W., Kang C., Rota P.A., Xu W., and Featherstone D. Proposal for genetic characterisation of wild-type mumps strains: preliminary standardisation of the nomenclature. Arch. Virol. 150 (2005) 1903-1909
26. Jorgensen E.D., Collins P.L., and Lomedico P.T. Cloning and nucleotide sequence of Newcastle disease virus hemagglutinin-neuraminidase mRNA: identification of a putative sialic acid binding site. Virology 156 (1987) 12-24
27. Kacprzak-Bergman I., Zaleska I., and Jasonek J. Specific humoral immunity in mumps meningitis in children. Med. Sci. Monit. 7 (2001) 977-981
28. Kolaskar A.S., and Kulkarni-Kale U. Sequence alignment approach to pick up conformationally similar protein fragments. J. Mol. Biol. 223 (1992) 1053-1061
29. Kolaskar A.S., and Kulkarni-Kale U. Prediction of three-dimensional structure and mapping of conformational epitopes of envelope glycoprotein of Japanese encephalitis virus. Virology 261 (1999) 31-42
30. Kolaskar A.S., and Tongaonkar P.C. A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett. 276 (1990) 172-174
31. Kovamees J., Rydbeck R., Orvell C., and Norrby E. Hemagglutinin-neuraminidase (HN) amino acid alterations in neutralization escape mutants of Kilham mumps virus. Virus Res. 17 (1990) 119-129
32. Kulkarni-Kale U., and Kolaskar A.S. Prediction of 3D structure of envelope glycoprotein of Sri Lanka strain of Japanese encephalitis virus. In: Chen Y.-P.P. (Ed). Conferences in Research and Practice in Information Technology 19 (2003) 87-96
33. Kulkarni-Kale U., Bhosle S., Manjari G.S., and Kolaskar A.S. VirGen: a comprehensive viral genome resource. Nucleic Acids Res. 32 (2004) D289-D292
34. Kulkarni-Kale U., Bhosle S., and Kolaskar A.S. CEP: a conformational epitope prediction server. Nucleic Acids Res. 33 (2005) W168-W171
35. Lamb R.A., Paterson R.G., and Jardetzky T.S. Paramyxovirus membrane fusion: lessons from the F and HN atomic structures. Virology 344 (2006) 30-37
36. Laskowski R.A., MacArthur M.W., Moss D.S., and Thornton J.M. Procheck: a program to check the stereochemical quality of protein structure. J. Appl. Crystallogr. 26 (1993) 283-291
37. Lawrence M.C., Borg N.A., Streltsov V.A., Pilling P.A., Epa V.C., Varghese J.N., McKimm-Breschkin J.L., and Colman P.M. Structure of the haemagglutinin-neuraminidase from human parainfluenza virus type III. J. Mol. Biol. 335 (2004) 1343-1357
38. Lim C.S., Chan K.P., Goh K.T., and Chow V.T. Hemagglutinin-neuraminidase sequence and phylogenetic analyses of mumps virus isolates from a vaccinated population in Singapore. J. Med. Virol. 70 (2003) 287-292
39. Lisowska E. The role of glycosylation in protein antigenic properties. Cell. Mol. Life Sci. 59 (2002) 445-455
40. Merz D.C., and Wolinsky J.S. Biochemical features of mumps virus neuraminidases and their relationship with pathogenicity. Virology 114 (1981) 218-227
41. Mirza A.M., Deng R., and Iorio R.M. Site-directed mutagenesis of a conserved hexapeptide in the paramyxovirus hemagglutinin-neuraminidase glycoprotein: effects on antigenic structure and function. J. Virol. 68 (1994) 5093-5099
42. Nagai T., Okafuji T., Miyazaki C., Ito Y., Kamada M., Kumagai T., Yuri K., Sakiyama H., Miyata A., Ihara T., Ochiai H., Shimomura K., Suzuki E., Torigoe S., Igarashi M., Kase T., Okuno Y., and Nakayama T. A comparative study of the incidence of aseptic meningitis in symptomatic natural mumps patients and monovalent mumps vaccine recipients in Japan. Vaccine (2006) [Jan 31, Epub ahead of print]
43. Ong G., Goh K.T., Ma S., and Chew S.K. Comparative efficacy of Rubini, Jeryl-Lynn and Urabe mumps vaccine in an Asian population. J. Infect. 51 (2005) 294-298
44. Orvell C., Alsheikhly A.R., Kalantari M., and Johansson B. Characterization of genotype-specific epitopes of the HN protein of mumps virus. J. Gen. Virol. 78 (1997) 3187-3193
45. Palomo C., Cane P.A., and Melero J.A. Evaluation of the antibody specificities of human convalescent-phase sera against the attachment (G) protein of human respiratory syncytial virus: influence of strain variation and carbohydrate side chains. J. Med. Virol. 60 (2000) 468-474
46. Paterson R.G., and Lamb R.A. RNA editing by G-nucleotide insertion in mumps virus P-gene mRNA transcripts. J. Virol. 64 (1990) 4137-4145
47. Petrescu A.J., Milac A.L., Petrescu S.M., Dwek R.A., and Wormald M.R. Statistical analysis of the protein environment of N-glycosylation sites: implications for occupancy, structure, and folding. Glycobiology 14 (2004) 103-114
48. Pipkin P.A., Afzal M.A., Heath A.B., and Minor P.D. Assay of humoral immunity to mumps virus. J. Virol. Methods 79 (1999) 219-225
49. Rafiefard F., Johansson B., Tecle T., and Orvell C. Characterization of mumps virus strains with varying neurovirulence. Scand. J. Infect. Dis. 37 (2005) 330-337
50. Ramachandran G.N., and Sasisekharan V. Conformation of polypeptides and proteins. Adv. Protein Chem. 23 (1968) 283-438
51. Rice P., Longden I., and Bleasby A. EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet. 16 (2000) 276-277
52. Rima B.K., Alexander D.J., Billeter M.A., Collins P.L., Kingsbury D.W., Lipkind M.A., Nagai Y., Orvell C., Pringle C.R., and ter Meulen V. Paramyxoviridae. In: Murphy F.A., Fauquet C.M., Bishop D.H.L., Ghabrial S.A., Jarvis A.W., Martelli G.P., Mayo M.A., and Summers M.D. (Eds). Virus Taxonomy. Sixth Report of the International Committee of Viruses (1995), Springer-Verlag, New York 268-274
53. Rost B., and O'Donoghue S. Sisyphus and prediction of protein structure. Comput. Appl. Biosci. 13 (1997) 345-356
54. Rubin S.A., Pletnikov M., and Carbone K.M. Comparison of the neurovirulence of a vaccine and a wild-type mumps virus strain in the developing rat brain. J. Virol. 72 (1998) 8037-8042
55. Rubin S.A., Pletnikov M., Taffs R., Snoy P.J., Kobasa D., Brown E.G., Wright K.E., and Carbone K.M. Evaluation of a neonatal rat model for prediction of mumps virus neurovirulence in humans. J. Virol. 74 (2000) 5382-5384
56. Rubin S.A., Afzal M.A., Powell C.L., Bentley M.L., Auda G.R., Taffs R.E., and Carbone K.M. The rat-based neurovirulence safety test for the assessment of mumps virus neurovirulence in humans: an international collaborative study. J. Infect. Dis. 191 (2005) 1123-1128
57. Saika S., Kidokoro M., Aoki A., and Ohkawa T. Neurovirulence of mumps virus: intraspinal inoculation test in marmosets. Biologicals 32 (2004) 147-152
58. Saito H., Takahashi Y., Harata S., Tanaka K., Sano T., Suto T., Yamada A., Yamazaki S., and Morita M. Isolation and characterization of mumps virus strains in a mumps outbreak with a high incidence of aseptic meningitis. Microbiol. Immunol. 40 (1996) 271-275
59. Sauder C.J., Vandenburgh K.M., Iskow R.C., Malik T., Carbone K.M., and Rubin S.A. Changes in mumps virus neurovirulence phenotype associated with quasispecies heterogeneity. Virology 350 (2006) 48-57
60. Seibel G., Singh U.C., Weiner P.K., Caldwell J., and Kollman P. AMfBER 3.0 revision A (1990), University of California at San Francisco, San Francisco
61. Sippl M.J. Recognition of errors in three-dimensional structures of proteins. Proteins 17 (1993) 355-362
62. Smith-Gill S.J. Molecular recognition of lysozyme by monoclonal antibodies. EXS 75 (1996) 277-300
63. Takahashi M., Nakayama T., Kashiwagi Y., Takami T., Sonoda S., Yamanaka T., Ochiai H., Ihara T., and Tajima T. Single genotype of measles virus is dominant whereas several genotypes of mumps virus are co-circulating. J. Med. Virol. 62 (2000) 278-285
64. Takimoto T., Taylor G.L., Crennell S.J., Scroggs R.A., and Portner A. Crystallization of Newcastle disease virus hemagglutinin-neuraminidase glycoprotein. Virology 270 (2000) 208-214
65. Takimoto T., Taylor G.L., Connaris H.C., Crennell S.J., and Portner A. Role of the hemagglutinin-neuraminidase protein in the mechanism of paramyxovirus-cell membrane fusion. J. Virol. 76 (2002) 13028-13033
66. Tanaka K., Baba K., Okada S., Okuno Y., Yamanishi K., Ueda S., Takahashi M., and Yamada A. Nasal antibody response to mumps virus after vaccination and natural infection. Vaccine 10 (1992) 824-827
67. Tecle T., Johansson B., Jejcic A., Forsgren M., and Orvell C. Characterization of three co-circulating genotypes of the small hydrophobic protein gene of mumps virus. J. Gen. Virol. 79 (1998) 2929-2937
68. Tecle T., Bottiger B., Orvell C., and Johansson B. Characterization of two decades of temporal co-circulation of four mumps virus genotypes in Denmark: identification of a new genotype. J. Gen. Virol. 82 (2001) 2675-2680
69. Tecle T., Mickiene A., Johansson B., Lindquist L., and Orvell C. Molecular characterisation of two mumps virus genotypes circulating during an epidemic in Lithuania from 1998 to 2000. Arch. Virol. 147 (2002) 243-253
70. Utz S., Richard J.L., Capaul S., Matter H.C., Hrisoho M.G., and Muhlemann K. Phylogenetic analysis of clinical mumps virus isolates from vaccinated and non-vaccinated patients with mumps during an outbreak, Switzerland 1998-2000. J. Med. Virol. 73 (2004) 91-96
71. Van Regenmortel M.H. Mimotopes, continuous paratopes and hydropathic complementarity: novel approximations in the description of immunochemical specificity. J. Dispers. Sci. Technol. 19 (1998) 1199-1219
72. Wheeler D.L., Barrett T., Benson D.A., Bryant S.H., Canese K., Chetvernin V., Church D.M., DiCuccio M., Edgar R., Federhen S., Geer L.Y., Helmberg W., Kapustin Y., Kenton D.L., Khovayko O., Lipman D.J., Madden T.L., Maglott D.R., Ostell J., Pruitt K.D., Schuler G.D., Schriml L.M., Sequeira E., Sherry S.T., Sirotkin K., Souvorov A., Starchenko G., Suzek T.O., Tatusov R., Tatusova T.A., Wagner L., and Yaschenko E. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 34 (2006) D173-D180
73. Wolinsky J.S. Mumps Virus (1996), Lippincott-Raven, Philadelphia
74. Wu T.T., and Kabat E.A. An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity. J. Exp. Med. 132 (1970) 211-250
75. Wu L., Bai Z., Li Y., Rima B.K., and Afzal M.A. Wild type mumps viruses circulating in China establish a new genotype. Vaccine 16 (1998) 281-285
76. Yates P.J., Afzal M.A., and Minor P.D. Antigenic and genetic variation of the HN protein of mumps virus strains. J. Gen. Virol. 77 (1996) 2491-2497
77. Yuan P., Thompson T.B., Wurzburg B.A., Paterson R.G., Lamb R.A., and Jardetzky T.S. Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose. Structure 13 (2005) 803-815
78. Zaitsev V., von Itzstein M., Groves D., Kiefel M., Takimoto T., Portner A., and Taylor G. Second sialic acid binding site in Newcastle disease virus hemagglutinin-neuraminidase: implications for fusion. J. Virol. 78 (2004) 3733-3741